MEDLINE INC

Medline Industries strengthens its N95 respirator leadership with robust supply chains, strict U.S. compliance, and a focus on quality—positioning it to meet growing global demand.

Medline Industries dominates the N95 respirator market, offering proven safety, high filtration, and robust compliance to meet evolving PPE demands worldwide.

Medline Inc. reports a half‑year 2026 rebound: net sales grow, operating income rises, and cash flow strengthens, underscoring robust profitability and strategic growth prospects in medical‑surgical products.

Medline Inc expands global reach with SteraMist®—new EU marketing deals, defense‑sector partnerships, and 99.99% microbial kill verified in field trials.

Medline Inc. Q1 2026: $2.45B revenue, $325M operating income, and strong oncology/immunology pipeline with Phase 3 and regulatory milestones, driving future growth.